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Membrane insertionCrystal (Cry) toxins are widely used for insect control, but their mechanism of toxicity is still uncertain. These
toxins can form lytic pores in vitro, and water soluble tetrameric pre-pore intermediates have been reported.
Even the precise oligomeric state of the toxin in membranes, trimeric or tetrameric, is still a debated issue.
Based on previous reports, we have assumed that interactions between toxin monomers in solution are at
least partly mediated by domain I, and we have analyzed in silico the homo-oligomerization tendencies of the
domain I α-helices individually. Using many homologous sequences for each α-helix, our strategy allows selec-
tion of evolutionarily conserved interactions. These interactions appeared only in helicesα3 andα5, but onlyα3
produced a suitably oriented or α-helical sample in lipid bilayers, forming homotetramers in C14-betaine, and
allowing determination of its rotational orientation in lipid bilayers using site-speciﬁc infrared dichroism
(SSID). The determined orientation in the tetrameric model is in agreement with only one of the evolutionarily
conserved models. In addition mutation R99E, which was found to inhibit oligomerization experimentally,
greatly destabilized the tetramer in molecular dynamic simulations. In this model, helix 3 is able to form
inter-monomer interactions without signiﬁcant rearrangements of domain I, which is compatible with
the available crystal structure of Cry toxins in solution. The model presented here at least partially explains
the reported tetrameric oligomerization of Cry toxins in solution and the inhibition of this oligomerization
by a synthetic α3 peptide.
© 2014 Elsevier B.V. All rights reserved.1. Introduction
The crystal (Cry) insecticidal toxins, or δ-endotoxins, are produced
by the Gram positive soil bacterium Bacillus thuringiensis (Bt). These
proteins are arranged in different classes [1] and are toxic to a wide va-
riety of insect larvae of the orders Coleoptera, Diptera and Lepidoptera
[2], having also a high speciﬁcity. For this reason, and since they are
safe for the environment, they are widely used as a biopesticide [3].
The three-dimensional structure of several Cry toxins has revealed a
similar three-domain arrangement [4–6]. Domain I has been suggested
to be a pore-forming domain [7–9] comprising seven α-helices, named
α1–α7. Domains II and III, composed of β-sheets, are responsible for
binding speciﬁcity and structural integrity [10].
The mechanism of action of Cry toxins takes place in several steps
(see [11], for a recent review). Brieﬂy, the crystal is solubilized in the
highly alkaline insect midgut lumen. Then, the toxins are activated pro-
teolytically by intestinal proteases. These activated toxins are able to
bind to speciﬁc receptors on the midgut brush border membrane5 6791 3856.(BBM) surface. After binding, it has been proposed that the toxin un-
dergoes a conformational change and inserts in the membrane, leading
to pore formation and cell lysis [12,13].
An alternative mechanism [14] has been suggested after observing
the effect of Cry1Ab toxin in non-susceptible insect cells that expressed
theManduca sexta Cry1Ab toxin receptor, Bt-R1: upon Cry toxin binding
to that receptor, a signal pathway is activated, which involves stimula-
tion of G protein and adenylyl cyclase, amongst others, leading to cell
death.
A striking difference between these two mechanisms is the role of
Cry oligomerization: whereas in the alternative model [14] only mono-
merswere found to be relevant for toxicity, in the pore-formingmodel a
water-soluble pre-pore intermediate has been postulated. Indeed, after
incubation of the toxin with a peptide that mimics the cadherin re-
ceptor, tetrameric oligomers were observed, which were suggested
to constitute the pore-forming unit [15–17]. These tetramers were
more active than the monomeric form, both in insertion and in
pore formation. More recent studies using single molecule ﬂuores-
cence have shown that in lipid bilayers B. thuringiensis Cry1Aa
forms oligomers when incorporated to lipid bilayers up to the level
of tetramer, although the presence of substantial amounts of trimers
in the membranes could not be discarded even at high toxin concen-
tration [18].
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α3 helix of domain I in Cry1Ab prevents pre-pore tetramer formation,
whereas synthetic peptides corresponding to the other helices in do-
main I did not have any effect in oligomerization [19]. This inhibitory
effect of α3 was attributed to competition of α3 peptide for the mono-
mer–monomer interfaces in the homo-tetramer. This is consistent with
the accessible position of helix α3 in the domain I of the water soluble
form of Cry toxins, e.g., [4,20]. In these structures, helices 1, 2, 3, 4 and
6 surround helices 5 and 7 (Fig. 1A), the latter being in contact with
domains II and II. A predicted coiled-coil propensity in helix α3 [19],
led the authors to suggest that positions a and d (Fig. 1) in a hypothetic
coiled-coil a-b-c-d-e-f-g repeat were involved in pre-pore tetramer
formation, i.e., in establishing the necessary contacts between Cry
monomers.
However, in the available crystal structures of Cry toxins, e.g., δ-
endotoxin Cry3A [20], positions a and d are involved in interactions
with helices of the same monomer, speciﬁcally with domain I helix
α5. Therefore, the proposition that positions a and d participate in
inter-monomer interactions would require a dramatic rearrangement
of theα3 helix, with a rotation of approximately 180°. Indeed,mostmu-
tations at positions a and d obtained to test the disruption of oligomer-
ization led to destabilization of the monomeric toxin [19], preventing
further investigation. This is expected from their orientation in the crys-
tal structure, facing α5. Of those that were stable, i.e., Y107E and L100E
(Fig. 1B, a positions), Y107E impaired both pre-pore oligomerization
and toxicity as expected from the hypothesis, but L100E conserved tox-
icity. In addition,mutations at positions other than a or d, e.g., position g
R99 [21], also impaired pore formation. These results therefore were
inconsistent with the hypothesis presented in terms of the orientation
of the α3 helix. However, if helix α3 prevents oligomerization, it
still may do so via interactions through the opposite face, i.e., posi-
tions b-f-c (Fig. 1A, broken line), which are solvent exposed in the
crystal structure of domain I.
In the present paper, using a computational approach [22], we have
ﬁrst sought to determine the predisposition of each one of theα-helices
in domain I of Cry toxins to form homomeric interactions. In this
approach, which we have applied previously to successfully predict
the homo-oligomeric association of various transmembrane (TM) α-
helical domains [23–28], non validmodels areﬁltered out by performing
independently the same simulation for a list of homologous sequences
that are likely to share the same backbone structure and oligomeric
size. The rationale is that multiple sequence variations present in these
sequences will eventually destabilize models that are not presentA
Fig. 1. (A) Crystal structure of Cry3a [20] with helices 1 to 6 indicated, and distribution of positio
(B) Alignment of 17 sequences used in theMD simulation corresponding to theα3 helix in Cry
are indicated on the right. In this alignment, residues labeled with a star (a and d) face the inte
synthesized.in vivo, but will preserve at least the native one, which will appear as a
stable structure simultaneously in the simulations of all sequences test-
ed. Such preservedmodel is referred to as a ‘complete set’, and is consid-
ered to represent a candidate for a native interaction. In the simulations,
we have used a dielectric constant of 80 and 1, to represent interactions
in solution and in the membrane, respectively. The likelihood of the
models obtained has been independently assessed using biophysical as-
says of these α-helical domains.
2. Materials and methods
2.1. Molecular dynamics simulations—global search
Simulations were performed using a Compaq Alpha Cluster SC45
which contains 47 nodes, and calculations were carried out using the
parallel version of the Crystallography and NMR System (CNS Version
0.3, PCNS) [29], as described elsewhere [30]. The protocol for the global
search and clustering of structures has been described previously [22,
24,25]. Brieﬂy, the global search was carried out in vacuo with united
atoms, explicitly describing only polar and aromatic hydrogen atoms
using CHI 1.1 (CNS Helical Interactions). As the models tested are
homooligomers, the interaction between the helices was assumed to
be symmetrical.
Trials were carried out starting from either left or right crossing
angle conﬁgurations. The initial helix tilt, β, was restrained to 0° and
the helices were rotated about their long helical axes in 10° increments
until the rotation angle reached 350°. Henceforth, the simulation was
repeated by increasing the helix tilt in discrete steps of 5°, up to 45°.
Three trials were carried out for each starting conﬁguration using differ-
ent initial random velocities.
Clusters were identiﬁed with a minimum number of eight similar
structures. Any structure belonging to a certain cluster was within 1.5
Å RMSD (root mean square deviation) from any other structure within
the same cluster. Finally, the structures belonging to each cluster were
averaged and subjected to energy minimization. These ﬁnal averaged
structures, described by a certain tilt and rotational orientation at a
speciﬁed arbitrary residue, were taken as the representatives of the re-
spective clusters. The tilt angle, β, of the models was taken as the aver-
age of the angles between the bundle axis and each helix axis in the
bundle. The bundle axis, coincident with the normal to the bilayer,
was calculated by CHI. The helix axis was calculated as a vector with
starting and end points above and below a deﬁned residue, where the
points correspond to the geometric mean of the coordinates of the ﬁveB
ns a–g in a helical wheel for helixα3 (the broken line indicates the solvent exposed face);
toxin homologs. Residue numbers correspond to the Cry1Ab sequence. Accession numbers
rior of domain I in the crystal structure [20]. The arrow shows the sequence of the peptide
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residue. The rotational orientation angleω of a residue is deﬁned by the
angle between a vector perpendicular to the helix axis, oriented to-
wards the middle of the peptidic C_O bond of the residue, and a
plane that contains both the helical axis and the normal to the bilayer.
Inter-sequence comparisons between low energy clusters were per-
formed by calculating the RMSD between their α-carbon backbone.
Fitting was performed using the program ProFit (http://www.bioinf.
org.uk/software/proﬁt). The energies calculated corresponded to the
total energy of the system, including both bonded and non-bonded,
e.g., bond, angle, dihedral, improper, and Van derWaals and electrostat-
ic terms, respectively [30]. The interaction energy for the residues was
calculated with the function chi_interaction implemented in CHI.
To ﬁnd the possible oligomeric state and mode of interaction, simu-
lations were performed with 17 homologous sequences of eachα-helix
in Cry toxin domain I, obtained from the National Center for Biotechnol-
ogy Information (NCBI). For each sequence, three trials were carried out
for each starting conﬁguration using different initial random velocities,
testing right and left-handed conﬁgurations, from dimers to pentamers,
and producing 51,840 structures for each helix-sequence. The correct
model amongst all these candidates has to be determined using comple-
mentary experimental data, e.g., site speciﬁc infrared dichroism, NMR
or crystallography. A complementary alternative is to perform these
simulations, not only for one sequence, but also for its homologues
[22,31], as these are supposed to share the same backbone structure.
Sequences used in the simulations for Cry3a were GALVS…EQVEA
(α2), AKNKA…SWQKN (α3), DIAEF…WYNV (α6) and SWVNF…ALFP
(α7), whereas the corresponding sequences for other homologs were
simply those obtained after alignment. Only those corresponding to
α3 are shown (Fig. 1B). The results for sequences α4 and α5 have
been reported previously [32], whereas helix α1 in Cry3a is only ~15
residues long, and it is cleaved after binding to receptors [16]; therefore,
it was not included in the analysis.
2.2. Molecular dynamics simulations—stability of helix α3 mutant R99E in
the tetrameric model 3
The tetrameric model 3 formed by α3 peptide from Cry8Aa, param-
eterized by the AMBER03d force ﬁeld, was taken as the initial structure
for simulationswith bothwild type (WT) andR99Emutant. In both sim-
ulations, the tetramer was initially placed in the center of a rectangular
boxwith a volume of 89.45 nm3, followed by addition of 2279 and 2281
TIP3P water molecules [33] into the box for WT and R99E, respectively.
Counter ions were added to the box forWT tomake the system neutral.
The pH was set to 7 with Arg and Lys residues positively charged, and
the Glu and Asp residues negatively charged. GROMACS (version 4.5)
software package was used to perform both simulations [34] The
LINCS protocol [35]was used to constrain the bonds involving hydrogen
atoms, allowing an integration time step of 2 fs. The particlemeshEwald
method [36] with a cutoff of 1.0 nm was used to treat the electrostatic
interactions. A cutoff of 1.2 nmwas used for the van der Waals interac-
tions. The non-bonded pair lists were updated every 0.010 ps. The coor-
dinates were saved every 2 ps. Temperature, 300 K, was controlled by
the Bussi–Donadio–Parrinello velocity rescaling thermostat found to
sample the canonical ensemble [37]. Both simulations ran for 50 ns.
2.3. Accessibility momentum calculation
The percentage of accessible surface of each residue was calculated
usingMolMol [38]. Thus, for each residue, accessibility was represented
by the length of a vector directed outwards from the center of the helix
towards the α-carbon of the corresponding residue. Vectors for all res-
idues were added to obtain the total accessibility momentum of the
helix, which should point towards its most solvent-accessible face. The
three terminal residues at each end of the peptide were not included
in the calculation, as these residues are exposed to solvent.2.4. Peptide synthesis and puriﬁcation
Peptides were synthesized using 9-ﬂuorenyl-methyloxycarbonyl
(FMOC) solid-phase chemistry (LibertyMicrowave Peptide Synthesizer,
CEM, NC, USA) and Tentagel amide resin (Intavis AG, Germany). The
peptides were cleaved from the resin with triﬂuoroacetic acid (TFA).
The lyophilized peptides were dissolved in acetonitrile, injected
into a C18 HPLC column, and eluted in a linear gradient of water/
acetonitrile, from 0% to 100% acetonitrile. Peptide purity was con-
ﬁrmed by electrospray ionization (ESI) mass spectrometry. The puri-
ﬁed peptides were lyophilized overnight after addition of 10 mM
HCl, to remove possible TFA adducts.2.5. 16O/18O exchange
To introduce the isotopically labeled amino acids, commercially
available 13C_16O labeled amino acids (Cambridge Isotopes Laborato-
ries, Andover, MA) A and L were exchanged to a double isotope,
13C_18O, by incubating the amino acid at 100 °C at acidic pH conditions
(pH ~1) with a mixture of H218O and dioxane (3:1, v/v) for 1 h, as de-
scribed previously [39]. The extent of exchange was monitored using
mass spectrometry. The solution was lyophilized and the amino acid
was derivatized with FMOC [40].2.6. Sequence and isotopic labeling
Orientation determination by site speciﬁc infrared dichroism SSID
[41] requires both α-helical conformation and order, and the latter
can be obtained if the peptide inserts in lipid bilayers. To conﬁrm the
rotational orientation obtained from the in silico analysis, the peptide
corresponding to helix α3 was taken from Cry8Aa (Fig. 1B, arrow)
because it showed the highest α-helical propensity, according to the
consensus predicted secondary structure from a set of twelve algo-
rithms [42]. Two differently labeled peptides were synthesized for this
sequence, each containing one 13C_18O -labeled carbonyl, one at
A144 and another at L145, equivalent to positions A106 and L107 in
Cry1Ab (V130KDKALAELKG LGNALDVYQQ SLEDWLEN158 (labeled resi-
dues underlined).
We also attempted to conﬁrm the orientation ofα5 helix reported in
[32] by synthesizing the α5 peptide. We used initially the sequence
Cry4Ba sequence ELLLLPIYAQ VANENLLLIR DGLINAQEWSL. However,
this peptide produced a low dichroism in the infrared spectra both for
amide I and A bands (not shown), indicative of either low order or a
not completely α-helical sample. In an attempt to obtain a more or-
dered peptide, we synthesized α5 from Cry1Ba2: LLMVYAQAAN
LHLLLLRDAS LFG (23 residues) and QEVPLLMVYA QAANLHLLLL
RDASLFGSEF (30 residues). The ﬁrst of these showed at least 50% of
β-structure, whereas the second was more α-helical, but the order
parameter was still negative. Lastly, we also synthesized a peptide
encompassing α4 and α5 (Q140SYRT…NAQEW199). However, none
of these peptides produced a sample suitable for SSID in lipid
bilayers.2.7. Circular dichroism (CD)
CD spectraweremeasured on a Chirascan CD Spectrometer (Applied
Photophysics, UK). Data were collected at 20 °C at 1 nm interval, from
190 nm to 240 nm, on a 1 mm pathlength cell, in 50 mM Tris,
100 mM NaCl, pH 7.3. The peptide concentration was 50 μM. The pep-
tide was ﬁrst dissolved in HFIP and dried, followed by resuspension in
the solution. When measuring the spectrum in the presence of deter-
gent, ﬁnal detergent concentration was 5 mM C-14 Betaine (cmc
100 μM). Spectra were smoothed with a Salvitsky–Golay algorithm.
BA
Fig. 2. Accessibility momenta for the four evolutionarily conserved models (1–4) relative
to domain I. (A), The four evolutionary conserved α3 homomeric models resulting from
our simulation; the direction of the accessibility momentum is indicated by an arrow. As
a reference, the α-carbon atom of S151 in helix α3 is shown as a pink sphere; (B), ribbon
representation of the crystal structure of domain I in Cry3A, with helices α1 (red), α2
(orange), α3 (light blue), α4 (yellow), α5 (dark blue), α6 (purple) and α7 (grey). The
four accessibility momenta in (A) (arrows labeled 1–4) are superimposed on the α3
helix in domain I, along with the accessibility vector of helix α3 in domain I (arrow
unnumbered), which indicates its most accessible side.
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Preliminary CD and AUC results indicated that in aqueous solution
the α3 peptide was found to adopt a random coil conformation and
no oligomers; therefore, AUC was performed in the presence of deter-
gents. Sedimentation equilibrium experiments were performed using
a Beckman XL-I analytical ultracentrifuge at 25 °C [43]. Absorbance
was measured at 250 nm (ε250 = 4367 M−1 cm−1). The buffer compo-
sition was 50 mM Tris, 100 mMNaCl, pH 7.3 and 5 mM C14 Betaine. To
match the density of the detergent, D2O was added to the buffer to a
ﬁnal volume ratio of 29.4% [44]. The monomeric molecular mass of the
α3 peptide and its partial speciﬁc volumewere calculatedwith the pro-
gram SEDNTERP [45]. The monomeric mass of the peptide was deter-
mined to be 3265 Da, whereas the partial speciﬁc volume, calculated
after correction for partial hydrogen/deuterium exchange [43], was
0.7421 cm3/g at 25 °C. The density-matched buffer was added to the
dry peptide. The concentration of detergent was 5 mM in all cells, and
the peptide:detergent molar ratio was 1:25, 1:50 and 1:100 for inner,
medium and outer cells, respectively. The samples were centrifuged in
three-compartment carbon-epoxy centerpieces with quartz windows
for lengths of time sufﬁcient to achieve equilibrium, tested with the
software WinMatch. Equilibrium was typically achieved after 26 h for
each speed: 30 K, 40 K and 48 K rpm. The equilibrium data sets were
processed and analyzed using the programs Sedﬁt and Sedphat [46].
At the end of each run, absorbance data at 250 nmwas obtained.
2.9. Infrared spectroscopy
Infrared spectra were acquired on a Nicolet Nexus spectrometer
(Madison, USA) purged with N2 and equipped with an MCT/A detector
cooled with liquid nitrogen. Attenuated total reﬂection (ATR) spectra
were collected with a 25-reﬂection ATR accessory from Graseby Specac
(Kent, UK) and a wire grid polarizer (0.25 μm, Graseby, Specac). A total
of 200 interferograms collected at a resolution of 4 cm−1 were proc-
essed with 1 point zero ﬁlling and Happ–Genzel apodization. The puri-
ﬁed peptide was incorporated in multilamellar liposomes by ﬁrst
dissolving a dry mixture of lipid and lyophilized peptide (50:1 molar
ratio) in HFIP. The solution was dried by a stream of N2, and the
resulting peptide-lipid ﬁlm was dissolved in phosphate buffer (1 mM,
pH 7) followed by sonication. The DMPC liposome solution was depos-
ited on a germanium internal reﬂection element (IRE) and dried slowly
by evaporation. Hydrogen/deuterium (H/D) exchange was performed
by ﬂowing D2O-saturated nitrogen into the ATR chamber for a few
hours. Amide proton H/D exchange was detected from the reduction
in intensity of amide A and II bands in the non-polarized spectra,
whichwere obtained fromparallel (∥) and perpendicular (⊥) ATRpolar-
ized spectra, using the expression 1(∥) + 1.44(⊥) [47]. Dichroic ratios
and percentage of H/D exchangewere calculated as described previous-
ly [48] and helix rotational orientationwas calculated as describedusing
SSID [41]. Order parameters were calculated essentially as described
[49].
3. Results and discussion
First, we performed molecular dynamic (MD) simulations to obtain
candidate models for homo-oligomerization. For each helix, 17 homo-
logs were used in order to test for evolutionary conservation of the
inter-helical interactions (see Materials and methods) as described
previously [22]. No ‘complete set’ was obtained from homo-dimeric to
homo-pentameric arrangements, at any helix tilt or rotational orienta-
tion tested, for α2, α6 or α7 helices (not shown). For α4 and α5, in a
previous report [32] we could only ﬁnd a conserved homotrimer for
α5, but no model for α4 [32]. These results are consistent with the
lack of effect on oligomerization by mutations at helix α6 [19] and α4
in Cry1Ab [50]. For helix α3, in contrast, we found four ‘complete sets’,
i.e., conserved models; two trimers and two tetramers, where theaccessibilitymoment, i.e., themost solvent-accessible side, is represent-
ed by a vector (Fig. 2A). These vectors should point towards the interior
of domain I in the crystal structure if Cry toxin monomer–monomer in-
teraction via α3 does not involve any large conformational change. As
shown in Fig. 2B, this condition is only satisﬁed by models 2 (trimer)
and 3 (tetramer). Similarly, it is difﬁcult to rationalize α5-mediated
interactions in solution, as this helix is embedded in domain I and not
accessible to solvent.
Nevertheless, to conﬁrm the type of oligomer, if any, formed by α3
andα5 helices, we synthesized these peptides. The interaction between
Cry toxinmonomers in solution is supposed to take place in the context
of a complete domain I; therefore, a synthetic peptide corresponding to
one of its α-helices may not be α-helical in aqueous solution. Indeed,
we found that this was the case for the peptides corresponding to
helix α3 and α5. Peptide α3 was soluble in water but it was not α-
helical (Fig. 3). When this peptide was analyzed by equilibrium sedi-
mentation in water, the sedimentation proﬁle was consistent with the
presence of only monomers, as the absorbance proﬁle was featureless
(not shown). However, when this peptide was solubilized in detergent,
CD experiments indicated that it was α-helical (Fig. 3), later conﬁrmed
by FTIR (see below). Thus, equilibrium sedimentation experiments of
α3 were performed in the detergent C14-betaine (Fig. 4A–B). The best
ﬁt to the data was obtained with a monomer: n-mer reversible equilib-
rium, where n=4 (i.e., tetrameric) (Fig. 4C–D) and Ka = 5 × 1010 M−3,
or 3.6 × 103 M−1, i.e., a Kd for monomer–monomer interaction of
approximately 0.3 mM.
It has been shown previously that inter-helical interactions in a de-
tergent environment are weaker than in lipid bilayers [51]. Thus it is
reasonable to assume that peptide α3 also forms oligomers in lipid bi-
layers, and that these oligomers are also tetrameric. We note that a tet-
rameric interaction has been proposed previously when the toxin is
inserted in membranes, on the basis of single molecule ﬂuorescence
[18] and as a pre-pore intermediate [19].
The fact that the peptide α3 is α-helical and forms oligomers in a
detergent environment, provides the opportunity to investigate its
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Fig. 3. Circular dichroism results corresponding to the synthetic peptide α3 in aqueous
solution (broken line) or in C14-betaine detergent micelles (solid line).
1781X. Lin et al. / Biochimica et Biophysica Acta 1838 (2014) 1777–1784rotational orientation in model planar lipid bilayers, provided that
the peptide inserts in membranes in an orientation almost perpen-
dicular to the membrane plane, as is expected for homo-oligomers
[41]. We note that this was not the case for a Cry3Aa α3 peptide
[49], which was claimed to adopt an orientation parallel to the mem-
brane surface, although in that work only the amide I infrared spec-
trum of one peptide, that of α2, was explicitly shown. In our hands,
however, α3 peptide from Cry8Aa was α-helical in lipid bilayers
and was properly inserted in the membrane (see below). This
allowed determination of the rotational orientation of this peptide
using site speciﬁc infrared dichroism (SSID) [41]. We measured the
orientation of two consecutive isotopically-labeled peptidic carbonyl
bonds (C_O), at A144 and at L145, by determination of the dichro-
isms of the amide A (N\Hs), amide I (C_Os) and (C_Os) (Fig. 5A),
using two independent measurements for each labeled peptide. For
the peptide labeled at amino acid A144, the values for amide A,5.9 6.0 6.1
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Fig. 4. Sedimentation equilibrium results for Cryα3-peptide inC-14 Betainemicelles. (A) Inner,
48,000 rpm (green), 40,000 rpm (blue) and 30,000 rpm (red). The data was best ﬁtted to a m
values for each of the models tested; (D) Graphical representation of the χ2 of each of the mod
cluded in the ﬁt.amide I and labeled carbonyl dichroisms were respectively (2.5,
2.4, 2) and (2.2, 2.1, 1.8). For the second peptide, labeled at L145,
these values were (2.4, 2.1, 2.4) and (2.3, 2.0, 2.2). Combining these
dichroisms, the rotational orientation of A144 was found to be 180° ±
17°, whereas the average α3 helix tilt from the membrane normal
was 24° ± 6°.
The rotational orientations of the equivalent residue A144 inmodels
1–4 (Fig. 2A) were determined to be 118°, 59°, 189° and 91°, respec-
tively. Thus, the only compatible model with our experimental mea-
surement by SSID (180° ± 17°) is model 3, which also satisﬁes our
experimental observations in terms of oligomeric size (tetrameric).
Further, in model 3, residues at positions labeled a and d are solvent
exposed, i.e., in the absence of structural rearrangements in the con-
text of a complete domain I, they would face helix α5 (Fig. 1A). That
is, only inmodel 3 the accessibility vector (Fig. 2B) coincideswith the
most buried face of α3 in domain I. In turn, the positions b-c-f in
model 3, which face the other α3 helices in the homotetramer, in
the context of a complete domain I would be exposed to solvent
and therefore available for domain I monomer–monomer interac-
tions without signiﬁcant domain I conformational change. Mutation
R99E in helix α3 of Cry1Aa was found to be a strong inhibitor of oligo-
merization [19,50]. This residue is at position g (Fig. 1), and it is involved
in inter-monomer interactions in our model 3 (Fig. 5B–C) consistent
with available mutagenesis data. In contrast, in the other tetrameric
model, this residue is facing the interior of the tetrameric bundle (not
shown). To test if this mutation is really critical for the stability of
model 3, we performed a molecular dynamics simulation (Fig. 6). For
the WT peptide, 11 clusters were found in total, and the largest cluster
was 72.8% of the population. For mutant R99E, 61 clusters were found,
and the largest cluster was only 14.8% of the population. While the
RMSD did not change for the WT peptide, the stability of the tetramer
was seriously compromised by the presence of the mutation, showing
an increase from 0.3 to 1.1 in 35 ns (Fig. 6A). The initial and ﬁnalmodels
in these simulations are shown in the same ﬁgure for WT and mutant
peptide (Fig. 6B–C).
Tetrameric model 3 for α3 helix interaction thus represents at least
part of the interactions between monomers that take place when the
complete toxin is still in solution. However, the fact that the present9 7.0 7.1
9 7.0 7.1
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Fig. 5. (A) ATR FTIR spectra of the synthetic Cryα3 peptide reconstituted in DMPC bilayers. The spectra show the Amide I (1700–1600 cm−1) region corresponding to the 0° (continuous
line) and 90° polarizations (broken line). The arrow indicates the band due to the isotopic label (13C_18O). For clarity, the band corresponding to the label is enlarged and shown in the
insert; (B–C) Side and top views of the tetramericmodel 3 in agreementwith the SSID orientation of theα3 peptide in lipid bilayers. The interfacial position of the residueArg99 in Cry1Ab
(equivalent to Glu in Cry8Aa, see Fig. 1B) is indicated; (D), spectra corresponding to synthetic Cry4Baα4–α5 peptide (top) andα5 (bottom) in DMPC at a P/L ratio 1:20, except for one of
the spectra of α5 at 1:100.
1782 X. Lin et al. / Biochimica et Biophysica Acta 1838 (2014) 1777–1784data was obtained in membranes suggests that the membrane embed-
ded form of the toxin also may use this interaction.
The fact that the peptide α3 wasα-helical in detergentmicelles and
in lipid membranes allowed determination of orientation by SSID, butA
B
C
Fig. 6. (A) Time evolution of RMSD against the initial tetrameric model 3 for WT (R99, black) a
(side and top view) taken after the simulation forWT (blue, B) andmutant R99E (red, C)α3 he
with a cutoff value of 2.5 Å. Shown structures are the middle structure of the largest cluster.this was not possible for helix α5, the other helix for which we found
an evolutionarily conserved model [32]. We synthesized a peptide cor-
responding to Cry4Ba α5, and also a peptide spanning both helices α4
and α5 (see Materials and methods section). However, α5 had theWT
R99E
nd mutant R99E (E99, red line); (B–C) initial model (green) and representative structures
lix. The structureswere obtained by RMSD-based clustering using single-linkage algorithm
1783X. Lin et al. / Biochimica et Biophysica Acta 1838 (2014) 1777–1784tendency to form a β-structure, and this was strongly dependent of the
protein/lipid ratio (Fig. 5D). Further, whenever the peptide was α-heli-
cal, the samplewas not amenable to orientation studies as the orderwas
too low. The syntheticα4–α5 peptide (Fig. 5D) did not have the tenden-
cy to form a β-structure and it was well inserted in lipid bilayers, with
80% protected residues after H/D exchange, but the amide I and A
dichroisms were too low (1.5 ± 0.08 and 2 ± 0.1), and the order
parameter was almost zero 0.02 ± 0.03, which again was unsuitable
to determine rotational orientations. It is likely that Cry4Baα5 requires
the presence of a full domain I or at least a more extended polypeptide
to order properly in the membrane.
One of the paradigms to explain toxicity is through formation of a
transmembrane pore [52] mediated by domain I [8], where oligomeri-
zation is necessary for toxicity [53], but not sufﬁcient [54,55]. Oligomers
have been observed after the toxin binds BBM vesicles [55–57] or
synthetic-lipid liposomes [54], using atomic force microscopy (AFM)
in model lipid bilayers [58,59], and a clear trimeric form was reported
using electron crystallography data obtained from 2D crystals [60]. A
“pre-pore” tetrameric oligomer of ~250 kD, that would form after inter-
action of Cry1 toxins with the cadherin receptor, has also been reported
[16,61,62], and has been proposed to be the pore-forming species. In the
so-called “umbrella”model [49], only helicesα4 andα5 of domain I are
inserted into the membrane as an α-helical hairpin [7,63], with the
remainingα-helices in domain I parallel to the membrane surface. Mu-
tagenesis and biophysical data indicate that helixα5 is involved in olig-
omerization, whereas helixα4 is lining the lumen of a putative channel
or pore [7]. Mutations at α4 which render the protein non-toxic, or re-
duce conductance in planar lipid bilayers, do not affect either oligomer-
ization [55,57] or binding to BBM vesicles [64,65]. In contrast, α5
mutations that affect toxicity generally also affect oligomerization [54,
55]. Further, synthetic α5 peptides, but not α4, oligomerize in solution
aswell as in membranes. This paper addsα3 to the list of oligomerizing
domain I peptides. Helix α7 may also insert in membranes, as reported
previously for Cry3a [49] and Cry4Ba [66]. In the latter paper, it was
found that the 27-residue α7 peptide folded as both α and β structures
in DMPC membranes, but complete β structure and α-helix were ob-
served in DDPC and DMPG, respectively [66]. In addition, these confor-
mationswere found to depend strongly on the protein/lipid ratio, as we
found for α5. For DMPC, for example, the proportion of α-helix in-
creased to 90% when the ratio was 1:100, versus a ~65% for a ratio of
1:30. The peptide was onlyα-helical in anionic DMPGmembranes, irre-
spective of the P/L ratio. Taken together, these results show that the so-
called ‘umbrella model’ may be in fact more complex than previously
anticipated, with helices α3, α4, α5 and α7 likely inserted in the lipid
bilayer in a concerted mechanism. It has been suggested that α7 may
serve as a binding sensor that could initiate the binding of the pore-
forming domain to the lipid membrane, facilitating the membrane in-
sertion of the α4–α5 pore-lining hairpin [49]. The model presented
herein suggests that α4 would be the main helix lining a hypothetic
pore, whereas bothα5 andα3would be involved in the oligomerization
of the toxin at themembrane. Recent studies using singlemolecule ﬂuo-
rescence have shown that B. thuringiensis Cry1Aa forms tetramers in
lipid bilayers, but substantial amounts of trimers were also observed
[18]. Thus the observation of α3 helix tetramerization (herein) and α5
helix trimerization [32] tendencies is signiﬁcant.
An alternative mechanism for toxicity is derived from observations
in insect cells that express the M. sexta Cry1Ab toxin receptor Bt-R1,
which show that toxicity originates from sequential activation by the
toxin monomer of a cell signaling pathway. This ultimately leads to
cell cytoskeleton destabilization [67] after translocation of the toxin
through themembrane. Bothmechanisms of toxicity require a tendency
of at least some of theα-helices in domain I to partition in lipid bilayers.
Finally, the possibility that the behavior of these individual helices is
different in the context of the complete domain I cannot be neglected.
In summary, our results support a tetrameric interaction of Cry
toxins in solutionmediated in part by helixα3.Whether this interactionoccurs only in solution, in the membrane, or in both environments is
still unknown in the absence of more data.
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